Income Statement Biomind Labs Inc.

Stocks

BMND.F

CA0907021012

Biotechnology & Medical Research

End-of-day quote OTC Markets Other stock markets 2026-07-17			5-day change	1st Jan Change
0.0335 ^USD	-29.77%		-63.63%	-70.61%

May. 15	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	Biomind Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

9464227756.CQ80P2bsUxTjmQtRa5fojBEcBepzUPlSpkD2Uxy0Syo.R2dmWl-GKVm5-FQ0XPOh4XVwRKcYP8Anwh-FOHr8P2JHS3dxVt0LJLTxUg

Published financial data: BIOMIND LABS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	1.45M	1.76M	662K	379K	422K
Stock-Based Compensation (IS)	1.38M	554K	7.5K	-	422K
R&D Expenses	571K	574K	307K	16.06K	-
Depreciation & Amortization - (IS)	28.32K	44.24K	15.15K	8.92K	2.23K
Other Operating Expenses, Total	3.43M	2.93M	991K	404K	847K
Operating Income	-3.43M	-2.93M	-991K	-404K	-847K
Interest Expense, Total	-3.71K	-1.36K	-161K	-32.64K	-68.71K
Net Interest Expenses	-3.71K	-1.36K	-161K	-32.64K	-68.71K
Currency Exchange Gains (Loss)	-64.46K	-49.31K	-26.56K	-21.28K	16.39K
Other Non Operating Income (Expenses)	-837K	-	-13.08K	193K	-23.53K
EBT, Excl. Unusual Items	-4.33M	-2.99M	-1.19M	-265K	-922K
Gain (Loss) On Sale Of Assets	-	-	-	-	72.04K
Other Unusual Items	-	-	-	4.53K	-
EBT, Incl. Unusual Items	-4.33M	-2.99M	-1.19M	-260K	-850K
Earnings From Continuing Operations	-4.33M	-2.99M	-1.19M	-260K	-850K
Net Income to Company	-4.33M	-2.99M	-1.19M	-260K	-850K
Net Income - (IS)	-4.33M	-2.99M	-1.19M	-260K	-850K
Net Income to Common Incl Extra Items	-4.33M	-2.99M	-1.19M	-260K	-850K
Net Income to Common Excl. Extra Items	-4.33M	-2.99M	-1.19M	-260K	-850K
Per Share Items
Net EPS - Basic	-0.06	-0.04	-0.02	-0	-0.01
Basic EPS - Continuing Operations	-0.06	-0.04	-0.02	-0	-0.01
Basic Weighted Average Shares Outstanding	72.06M	74.76M	74.76M	76.15M	77.57M
Net EPS - Diluted	-0.06	-0.04	-0.02	-0	-0.01
Diluted EPS - Continuing Operations	-0.06	-0.04	-0.02	-0	-0.01
Diluted Weighted Average Shares Outstanding	72.06M	74.76M	74.76M	76.15M	77.57M
Normalized Basic EPS	-0.04	-0.02	-0.01	-0	-0.01
Normalized Diluted EPS	-0.04	-0.02	-0.01	-0	-0.01
Supplemental Items
EBITDA	-3.4M	-2.93M	-985K	-396K	-844K
EBITA	-3.43M	-2.93M	-991K	-404K	-847K
EBIT	-3.43M	-2.93M	-991K	-404K	-847K
Normalized Net Income	-2.71M	-1.87M	-745K	-166K	-577K
Interest on Long-Term Debt	3.71K	1.36K	87	-	68.71K
Supplemental Operating Expense Items
General and Administrative Expenses	1.45M	1.76M	662K	379K	422K
Research And Development Expense From Footnotes	571K	574K	307K	16.06K	-
Stock-Based Comp., Other (Total)	1.38M	554K	7.5K	-	422K
Total Stock-Based Compensation	1.38M	554K	7.5K	-	422K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.27M	26.16K	24.26K	147	36
Total Cash And Short Term Investments	2.27M	26.16K	24.26K	147	36
Prepaid Expenses	166K	18.78K	-	-	-
Other Current Assets, Total	-	-	20.95K	20.95K	-
Total Current Assets	2.44M	44.93K	45.22K	21.1K	36
Gross Property Plant And Equipment	117K	117K	117K	44.59K	-
Accumulated Depreciation	-28.32K	-72.56K	-87.71K	-24.53K	-
Net Property Plant And Equipment	88.37K	44.13K	28.98K	20.06K	-
Total Assets	2.53M	89.06K	74.2K	41.16K	36
Liabilities
Accounts Payable, Total	290K	329K	561K	447K	390K
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	-	-	739K	671K	728K
Current Portion of Leases	35.06K	8.16K	-	-	-
Other Current Liabilities	-	-	206K	224K	617K
Total Current Liabilities	325K	337K	1.51M	1.34M	1.74M
Long-Term Leases	10.26K	-	-	-	-
Total Liabilities	335K	337K	1.51M	1.34M	1.74M
Common Stock, Total	11.1M	11.1M	11.1M	11.45M	11.45M
Retained Earnings	-10.45M	-13.43M	-14.62M	-14.88M	-15.74M
Comprehensive Income and Other	1.54M	2.08M	2.09M	2.14M	2.55M
Total Common Equity	2.19M	-248K	-1.43M	-1.3M	-1.74M
Total Equity	2.19M	-248K	-1.43M	-1.3M	-1.74M
Total Liabilities And Equity	2.53M	89.06K	74.2K	41.16K	36
Supplemental Items
ECS Total Shares Outstanding on Filing Date	74.76M	74.76M	74.76M	77.57M	77.57M
ECS Total Common Shares Outstanding	74.76M	74.76M	74.76M	77.57M	77.57M
Book Value / Share	0.03	-0	-0.02	-0.02	-0.02
Tangible Book Value	2.19M	-248K	-1.43M	-1.3M	-1.74M
Tangible Book Value Per Share	0.03	-0	-0.02	-0.02	-0.02
Total Debt	45.32K	8.16K	739K	671K	728K
Net Debt	-2.23M	-17.99K	715K	671K	728K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	44.59K	44.59K	44.59K	44.59K	-
Full Time Employees	9	5	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-4.33M	-2.99M	-1.19M	-260K	-850K
Depreciation & Amortization - CF	28.32K	44.24K	15.15K	8.92K	2.23K
Depreciation & Amortization, Total	28.32K	44.24K	15.15K	8.92K	2.23K
(Gain) Loss From Sale Of Asset	-	-	-	-	-72.04K
Stock-Based Compensation (CF)	1.38M	554K	7.5K	-	422K
Other Operating Activities, Total	905K	50.68K	174K	-150K	109K
Change In Accounts Payable	25.77K	38.93K	232K	47.18K	301K
Change in Other Net Operating Assets	-130K	147K	-2.17K	-	20.95K
Cash from Operations	-2.12M	-2.15M	-766K	-354K	-67.55K
Capital Expenditure	-44.59K	-	-	-	-
Cash Acquisitions	250	-	-	-	-
Cash from Investing	-44.34K	-	-	-	-
Short Term Debt Issued, Total	-	-	771K	307K	86.34K
Total Debt Issued	-	-	771K	307K	86.34K
Long-Term Debt Repaid, Total	-30.5K	-38.52K	-8.25K	-	-
Total Debt Repaid	-30.5K	-38.52K	-8.25K	-	-
Issuance of Common Stock	4.5M	-	-	-	-
Other Financing Activities, Total	-	-	-	-5.11K	-
Cash from Financing	4.47M	-38.52K	762K	302K	86.34K
Foreign Exchange Rate Adjustments	-	-58.1K	1.58K	28.06K	-18.9K
Net Change in Cash	2.3M	-2.25M	-1.89K	-24.12K	-111
Supplemental Items
Levered Free Cash Flow	-845K	-1.05M	-262K	-361K	210K
Unlevered Free Cash Flow	-843K	-1.05M	-161K	-340K	253K
Change In Net Working Capital	65.14K	-186K	-436K	96.32K	-357K
Net Debt Issued / Repaid	-30.5K	-38.52K	762K	307K	86.34K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-167.52	-140.18	-759.08	-438.25	-2.57K
Return on Total Capital	-209.06	-183.53	132.93	38.23	64.66
Return On Equity %	-432.34	-306.94	141.98	19.07	56.02
Return on Common Equity	-432.34	-306.94	141.98	19.07	56.02
Short Term Liquidity
Current Ratio	7.51	0.13	0.03	0.02	0
Quick Ratio	7	0.08	0.02	0	0
Operating Cash Flow to Current Liabilities	-6.54	-6.39	-0.51	-0.26	-0.04
Long Term Solvency
Total Debt/Equity	2.07	-3.3	-51.62	-51.58	-41.97
Total Debt / Total Capital	2.02	-3.41	-106.72	-106.54	-72.33
LT Debt/Equity	0.47	-	-	-	-
Long-Term Debt / Total Capital	0.46	-	-	-	-
Total Liabilities / Total Assets	13.25	378.07	2.03K	3.26K	4.82M
EBIT / Interest Expense	-923.15	-2.16K	-6.14	-12.39	-12.32
EBITDA / Interest Expense	-907.9	-2.12K	-6.05	-12.12	-12.29
(EBITDA - Capex) / Interest Expense	-919.91	-2.12K	-6.05	-12.12	-12.29
Total Debt / EBITDA	-0.01	-0	-0.76	-1.7	-0.86
Net Debt / EBITDA	0.66	0.01	-0.73	-1.7	-0.86
Total Debt / (EBITDA - Capex)	-0.01	-0	-0.76	-1.7	-0.86
Net Debt / (EBITDA - Capex)	0.65	0.01	-0.73	-1.7	-0.86
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	-13.93	-66.34	-59.83	113.48
EBITA, 1 Yr. Growth %	-90.66	-14.38	-66.22	-59.21	109.32
EBIT, 1 Yr. Growth %	-90.66	-14.38	-66.22	-59.21	109.32
Earnings From Cont. Operations, 1 Yr. Growth %	-88.19	-31.09	-60.06	-78.16	226.48
Net Income, 1 Yr. Growth %	-88.19	-31.09	-60.06	-78.16	226.48
Normalized Net Income, 1 Yr. Growth %	-88.19	-31.09	-60.06	-77.78	248.09
Diluted EPS Before Extra, 1 Yr. Growth %	-93.32	-33.58	-60.06	-78.56	220.53
Net Property, Plant and Equip., 1 Yr. Growth %	-	-50.06	-34.32	-30.78	-
Total Assets, 1 Yr. Growth %	8.43K	-96.48	-16.69	-44.53	-99.91
Tangible Book Value, 1 Yr. Growth %	-1.26K	-111.29	478.27	-9.21	33.49
Common Equity, 1 Yr. Growth %	-1.26K	-111.29	478.27	-9.21	33.49
Cash From Operations, 1 Yr. Growth %	-82.31	1.33	-64.39	-53.73	-80.94
Levered Free Cash Flow, 1 Yr. Growth %	-	12.16K	-75.11	37.84	-158.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-	16.7K	-84.7	111.65	-174.32
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	-46.18	-63.23	-7.4
EBITA, 2 Yr. CAGR %	-	-71.72	-46.22	-62.88	-7.59
EBIT, 2 Yr. CAGR %	-	-71.72	-46.22	-62.88	-7.59
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-71.47	-47.54	-70.46	-15.55
Net Income, 2 Yr. CAGR %	-	-71.47	-47.54	-70.46	-15.55
Normalized Net Income, 2 Yr. CAGR %	-	-71.47	-47.54	-70.21	-12.05
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-78.93	-48.49	-70.74	-17.1
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-42.73	-32.57	-
Total Assets, 2 Yr. CAGR %	-	73.32	-82.87	-32.02	-97.8
Tangible Book Value, 2 Yr. CAGR %	-	14.52	-19.19	129.13	10.09
Common Equity, 2 Yr. CAGR %	-	14.52	-19.19	129.13	10.09
Cash From Operations, 2 Yr. CAGR %	-	-57.66	-39.93	-59.41	-70.3
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	452.43	-41.43	-10.43
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	407.08	-43.09	25.42
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	-51.18	-33.92
EBITA, 3 Yr. CAGR %	-	-	-69.99	-50.95	-33.93
EBIT, 3 Yr. CAGR %	-	-	-69.99	-50.95	-33.93
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-68.09	-60.82	-34.2
Net Income, 3 Yr. CAGR %	-	-	-68.09	-60.82	-34.2
Normalized Net Income, 3 Yr. CAGR %	-	-	-68.09	-60.6	-32.4
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-73.92	-61.54	-35.01
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-39	-
Total Assets, 3 Yr. CAGR %	-	-	35.77	-74.65	-92.61
Tangible Book Value, 3 Yr. CAGR %	-	-	96.47	-15.99	91.37
Common Equity, 3 Yr. CAGR %	-	-	96.47	-15.99	91.37
Cash From Operations, 3 Yr. CAGR %	-	-	-60.04	-44.93	-68.45
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	247.78	-41.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	278.95	-37.8
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	-	-	-52.94
EBIT, 5 Yr. CAGR %	-	-	-	-	-52.94
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-52.9
Net Income, 5 Yr. CAGR %	-	-	-	-	-52.9
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-52.13
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-58.58
Total Assets, 5 Yr. CAGR %	-	-	-	-	-73.89
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	55.84
Common Equity, 5 Yr. CAGR %	-	-	-	-	55.84
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-64.51